Objective: Ipsilateral antegrade access (AA) is an alternative access to contralateral retrograde access (RA) to treat infrainguinal occlusive disease. Our goal was to assess whether this technique is associated with higher access site complications.
Methods: The Vascular Quality Initiative database was analyzed from 2010 to 2017 for all infrainguinal peripheral vascular endovascular interventions. We excluded all cases in which there was not one singular access through the common femoral artery. Access type was classified as AA or RA on the basis of the approach. Propensity matching and multivariable analysis were used to determine the effect of AA on access site complications.
Results: There were 45,816 accesses identified (6600 AAs and 39,216 RAs). AA patients were older (70.7 vs 69.1 years), more often were male (66.5% vs 59.1%) and white (79.4% vs 74.6%), and more often had Medicare (58.4% vs 56.6%); less often they were obese (29.3% vs 36.1%), were currently smoking (25.5% vs 28.7%) and diabetic (56% vs 59.8%), had chronic obstructive pulmonary disease (20.7% vs 21.8%), and were ambulatory (69.8% vs 72.5%; P < .05 for all). AA patients were more likely to have a previous inflow stent (9.3% vs 7%), inflow bypass (6.2% vs 1.8%), and contralateral leg bypass (6.3% vs 3.9%; P < .01 for all). There was no difference in preoperative aspirin use (71.6% vs 72.4%); however, clopidogrel use was less in AA (33.9% vs 36.4%), and preoperative anticoagulation use was higher in AA patients (16.9% vs 14.3%; P < .01 for both). AA was more often used in the setting of tissue loss (51.8% vs 45.1%) and for tibial intervention (46.3% vs 35.3%; P < .01 for both). There was no difference between AA and RA in overall hematoma (3% vs 2.7%; P ¼ .21) or hematoma requiring intervention (0.4% vs 0.4%; P ¼ .75) rates. There was no difference in access site occlusion or stenosis (0.2% vs 0.3%; P ¼ .68). These findings were confirmed with 2:1 matching based on preoperative data and type of intervention. Multivariable analysis showed that AA was not associated with any hematoma (odds ratio, 0.87; 95% confidence interval, 0.74-1.02; P ¼ .08) or hematoma requiring intervention (odds ratio, 1.14; 95% confidence interval, 0.74-1.74; P ¼ .56).
Conclusions: AA is safe and is not associated with increased access site complications. This approach remains a viable alternative to traditional RA when it is more feasible. 
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Objective: We previously proposed a grading system for thoracic blunt aortic injury (TBAI) designed to guide therapy. This study analyzes our outcomes since implementing this system.
Methods: A single-center, retrospective study was conducted of consecutive patients presenting with TBAI between January 2014 and December 2017. The grading system classified injuries into minimal, moderate, or severe on the basis of computed tomography imaging. Clinical end points included timing of operation and mortality. Secondary end points included associated injuries, aortic anatomy, and operative details as well as 30-day follow-up.
Results: During the study period, 87 patients with TBAI were identified. Table I contains demographic and anatomic features. A comparison of our grading system and the Society for Vascular Surgery grading system is seen in Table II . The majority of patients had a moderate injury occurring distal to the left subclavian artery (LSA); 59 patients underwent thoracic endovascular aortic repair (TEVAR), whereas none of the patients with minimal injury (n ¼ 24) required surgical treatment. The mean time to repair was 53 hours (1-191 hours) for moderate injury and 3.6 hours for severe injury (0-7 hours). Operative details are shown in Table II . The average diameter and length of the endograft was 26 mm and 112 cm, respectively, and the LSA was covered in 43% of patients. Intravascular ultrasound to confirm sizing was used in 83% of cases. Most patients (92%) received intravenous heparin during TEVAR, whereas the remainder received only heparin sheath flush because of concern for intracranial hemorrhage. None of the patients underwent LSA revascularization or developed stroke or spinal cord ischemia as a result of the procedure. Operative complications were seen in 6% of patients and included one femoral pseudoaneurysm, one lower extremity compartment syndrome, one type II endoleak requiring LSA embolization, and one intracranial bleed. The 30-day mortality was 7% (n ¼ 1 aorta related). On 30-day postoperative follow-up, computed tomography imaging uniformly revealed positive aortic remodeling, and no secondary aortic intervention was required.
Conclusions: Institutional implementation of our grading system has streamlined treatment of TBAI, and our results confirm the following: patients with minimal injury do not require surgical treatment; patients with moderate injury can safely undergo TEVAR in a semielective manner once they are stable from other injuries; and patients with severe injury require emergent repair. These procedures are expeditious and can be successfully performed percutaneously with a single endograft. Complications are rare, and follow-up reveals excellent remodeling of the aorta, likely resulting in longer interval surveillance requirements for these patients. Objective: Patients with end-stage renal disease can exhaust all upper extremity access options. Lower extremity access is often considered for the next vascular access option in these patients. We describe our contemporary experience with the autogenous femoral vein transposition arteriovenous fistula (FVT).
Methods: All FVTs performed at an academic medical center were analyzed from 2006 to 2017. FVTs were placed after upper extremity access was deemed no longer feasible. The patients' demographics, comorbidities, and access history were described, and perioperative and long-term outcomes were analyzed.
Results: Eighteen patients who received FVT were identified. Mean age was 56 6 12 years; 28% were female, and 67% were African American. Comorbidities included hypertension (100%), coronary artery disease (67%), diabetes (67%), congestive heart failure (50%), and obesity (39%). The median number of previous upper extremity accesses was three, and all patients dialyzed through a tunneled line at the time of the operation. The median operative time was 255 minutes, and estimated blood loss was 150 mL. Preanastomotic banding was performed in 89% of cases.
Four (22.2%) patients returned to the operating room within 30 days for drainage of thigh abscess, revision and thrombectomy of the access, hematoma drainage, and colectomy for Clostridium difficile colitis. Other perioperative complications included wound complications (27.8%), deep venous thrombosis (5.6%), myocardial infarction (non-ST-segment elevation myocardial infarction; 5.6%), pneumonia (5.6%), and urinary tract infection (5.6%). Distal arterial ischemia requiring revascularization occurred in one (5.9%) patient at 6 months. No patients died within 30 days, whereas one died within 90 days. Three patients had an emergency department visit within 30 days and two were admitted. Eighty percent of patients' FVTs matured, and they underwent successful dialysis through the FVT. At 1 year, primary patency was 73.5%, assisted primary patency was 94.1%, and secondary patency was 94.1%.
Conclusions: FVT provides excellent long-term durability in patients with limited dialysis options. It should be considered in appropriate-risk patients who have exhausted their upper extremity options.
